Stay updated on Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page update adds site revision v3.4.3 and removes v3.4.2, indicating an administrative update to the site.
    Difference
    0.0%
    Check dated 2026-03-06T18:45:44.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed Revision: v3.4.1, reflecting a minor site version update.
    Difference
    0.0%
    Check dated 2026-02-13T12:38:05.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added and Revision: v3.4.0 was removed.
    Difference
    0.0%
    Check dated 2026-02-05T23:49:00.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Minor revision update observed: the page shows Revision: v3.3.4 (replacing v3.3.3), with no changes to study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T04:43:07.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The Locations section adds numerous new sites across the US, Canada, Europe, Australia, and other regions, and removes many previously listed sites. This expands and reduces where participants can enroll in the study.
    Difference
    3%
    Check dated 2025-12-24T14:11:32.000Z thumbnail image
  8. Check
    112 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.2.0 was removed from the page.
    Difference
    0.3%
    Check dated 2025-11-25T13:31:46.000Z thumbnail image

Stay in the know with updates to Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial page.